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1. Introduction 
Intracranial atherosclerotic stroke (ICAS) is responsible for ischemic stroke in 10~33%.1-3  
ICAS occurs in association with various stroke mechanisms, such as in situ thrombotic 
occlusion, artery-to-artery embolism, hemodynamic insufficiency, and branch occlusion.4 
Various radiologic stroke patterns are associated with ICAS, from single and small 
subcortical perforator infarctions to multiple cortical infarctions [Figure 1].5,6 
The characteristics of ICAS and the role of MRI and magnetic resonance angiography (MRA) 
are discussed herein. 
Thrombotic 
occlusion 
(rare)
Plaque image
T2            Contrast
Microembolic signal (arrow)
Artery-to-artery 
embolism 
(common)
Hemodynamic 
impair (rare)
Branch 
atheromatous 
disease (common)
Mechanisms        TOF-MRA                       DWI                                                            PWI
 
Fig. 1. Various mechanisms of stroke in patients with intracranial atherosclerosis. 
www.intechopen.com
 Magnetic Resonance Angiography Basics to Future 
 
52
2. Hemodynamic characteristics of ICAS  
Despite of the diversity in stroke mechanisms of ICAS, ICAS has unique hemodynamics 
features compared to other stroke subtypes.  
2.1 Pre-stroke hemodynamic status in patients with intracranial atherosclerosis 
The balance of occlusion and collaterals determines the hemodynamic circumstance or 
blood flow changes that challenge the brain. Depending on the time course, such changes 
may have radically discrepant effects. Collateral circulation is a potent determinant of 
recurrent stroke risk in symptomatic ICAS, demonstrating a protective role with severe 
stenoses and identifying more unstable milder stenosis.7 In addition, there are increasing 
evidences that ischemic preconditioning can induce tolerance by raising the threshold of 
tissue vulnerability in human brain.8-10 Although ischemic brain injuries resulting from focal 
decrease in perfusion cause ischemic brain damage, patients with preceding less severe 
ischemic stimuli (i.e. transient ischemic attacks) showed less likely to have stroke and more 
likely to have good outcome after stroke.8, 11 Longstanding hemodynamic compromise 
which was frequently observed in intracranial atherosclerosis may elicit collateral 
development and preconditioning to adapt to recurrent ischemia.12 Thus, it is conceivable 
that patients with intracranial atherosclerosis may be ‘prepared’ and ‘preconditioned' for the 
risk of subsequent stroke. 
2.2 Hemodynamic feature in patients with ICAS 
The most common techniques for imaging the ischemic penumbra in acute ischemic 
patients are (a) combined diffusion-weighted imaging (DWI) and perfusion-weighted 
imaging (PWI) and (b) combined DWI and MRA.13-15 ICAS had a typical PWI–DWI (a 
large mismatch region but less severe hypoperfusion) and MRA–DWI mismatch profiles 
(a stenosis or occlusion of large intracranial vessels but a small core region), which have 
been reported to be associated with favorable outcomes after recanalization therapy.16, 17 
The differences in PWI–DWI and MRA–DWI mismatch profiles between ICAS and other 
stroke mechanisms may be related to differences in pretreatment collateral flow status 
[FIGURE 2].17 Moreover, patients with ICAS had increased CBV when compared to 
patients with cardioembolic stroke.18 Patients with ICAS had a good collateral grade than 
those with other subtypes.17, 19, 20 
2.3 Stroke evolution, outcomes and recurrence after ICAS 
There were two types of stroke evolution had different pathophysiological mechanisms.21 
Specifically, the large mild perfusion delay was associated with new lesions, whereas the 
large initial DWI lesions and a severe perfusion delay were associated with lesion growth.21 
Because patients with ICAS had relatively mild perfusion delay in their pretreatment MRI 
that were related to mostly multiple and small recurrent lesions, they may had minimal 
infarct growth [Figure 2].16 Similarly, ICAS as a stroke mechanism resulted in favorable 
clinical outcomes. Benign pretreatment MR profiles which were associated with good 
collaterals of ICAS patients may explain these results.16  
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Fig. 2. Typical examples of intracranial atherosclerotic stroke. Initial MR shows typical PWI 
(B)-DWI (A) (a large salvageable area but less severe hypoperfusion) and MRA (C)-DWI (A) 
(a severe stenosis of right middle cerebral artery (white arrow) but a small core region). 
Digital subtraction angiography (D) demonstrates a severe stenosis in the same location 
(arrow head, arterial phase) and adequate leptomeningeal collateral flow from right anterior 
cerebral artery (black arrows, capillary phase). Follow-up DWI (E) reveals minimal infarct 
growth.  
On the contrary, recurrent ischemic lesions during the first week after the onset of stroke in 
ICAS are relatively frequent compared to other stoke subtypes.22 In clinical aspects, many 
patients with ICAS have recurrent cerebral ischemic events despite standard medical 
therapy with antiplatelet agents or oral anticoagulants.23 The pattern of recurrence differed 
between intracranial and extracranial atherosclerotic stroke.22, 24 Unlike the patients with 
carotid atherosclerosis who were unpredictable with respect to the site of recurrence and 
degree of preexisting stenosis, patients with ICAS usually recurred within the same territory 
as the index stroke which was associated with progression of stenosis.5, 22, 24, 25 Collateral 
circulation is a potent determinant of recurrent stroke risk in symptomatic ICAS, 
demonstrating a protective role with severe stenoses and identifying more unstable milder 
stenosis.7  
3. Vascular imaging in patients with ICAS  
3.1 Vascular studies for luminal imaging 
Digital subtraction angiography (DSA) is the current gold standard for the diagnosis of 
intracranial atherosclerosis. However, DSA is invasive and carries the risk of stroke. Along 
with transcranial Doppler (TCD) and computed tomographic angiography (CTA), MRA is 
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less invasive techniques and has emerged as a more popular modality for visualization of 
intracranial vessels [Figure 3].  
 
Fig. 3. A patient with intracranial stenosis on the left proximal middle cerebral artery. (A) 
DSA, (B) CTA, (C) TOF MRA, and (D) TCD findings. 
Two MRA techniques used to detect intracranial stenosis are the 3D time-of-flight (TOF) 
MRA and contrast-enhanced MRA (CE-MRA). The Stroke Outcomes and Neuroimaging of 
Intracranial Atherosclerosis (SONIA) trial compared the accuracy of TOF MRA with DSA. 
SONIA demonstrated that TOF MRA have a good negative predictive value (89-93%) for 
excluding the presence of 50 to 99% intracranial atherosclerotic stenosis but relatively low 
positive predictive value (54-65%).26, 27 CE-MRA is less studies for intracranial vessels 
because of technical issues. It has been thought that CE-MRA can lessen the problem of 
overestimation of the length and degree of stenosis, a common obstacle with 3D-TOF MRA 
by decreased dependence of flow signal intensity and T1 shortening effects of fat and 
calcium.28, 29 However, recent studies suggested that TOF MRA provides comparable 
diagnostic performance with CE-MRA for intracranial stenosis with development of various 
TOF MRA sequence.30, 31 
Recent advances in MRI techniques enable visualization of small perforating vessels 
originated from large intracranial arteries [Figure 4 D].32 The Warfarin-Aspirin Symptomatic 
Intracranial Disease (WASID) trial investigators showed that the degree of stenosis (the 
presence of severe stenosis of ≥70%) was associated with subsequent ischemic stroke in the 
territory of the stenotic artery.33 On the contrary, not only stenosis of severe degree but also 
stenosis of a milder degree on the symptomatic vessels should be taken into account, 
especially in patients with deep infarcts (branch occlusive disease). Physicians may consider 
a mild degree of stenosis to be irrelevant. However, large intracranial arteries have many 
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deep perforators, and mild stenosis may occlude these deep perforators' orifices, resulting in 
stroke in the absence of plaque rupture or platelet activation. A follow-up study of patients 
with various subtypes of ischemic stroke demonstrated that, in patients with diagnoses of 
lacunar stroke at the time of their index strokes, physicians often found intracranial stenoses 
upon these patients' recurrences.34  
D
E
 
Fig. 4. Application of high resolution MRI. Contrast-enhanced MRI for plaque image (A-C), 
and 7-tesla MRA for small perforating arteries (D) and pial branches of leptomeningeal 
collaterals (E).  
3.2 MRI for wall/plaque image  
Patients with ICAS often have tandem lesions. Based on MRA, 65 out of 238 patients (27.3%) 
had coexistent asymptomatic intracranial stenosis. During a mean follow-up period of 1.8 
years, 5 ischemic strokes (5.9%) occurred in the asymptomatic intracranial atherosclerotic 
stenosis territory (risk at 1 year=3.5%).35 Thus, it is important to differentiate ‘high-risk’ 
stenosis and so called ‘stable’ (low-risk) stenosis.  
There has been a growing body of interest in the role of MRI for imaging the vessel wall or 
the plaque. Autopsy series observed atherosclerotic plaques in intracranial vessels of 45.5-
62.5% of subjects.36,37 High-resolution MRI could provide the information on the presence 
and the volume of plaque.38, 39 Plaque was clearly identified as plaque enhancement after 
gadolinium injection [Figure 4 A~C].39  
MRI for plaque imaging is a potentially promising tool that can be used in clinical practice 
for patients with ICAS. First, this can be useful in evaluating the mechanisms of stroke, i.e. 
demonstrating the presence of intracranial plaque in patients with cryptogenic stroke. High-
resolution MRI to determine the presence of plaque revealed that MRI detects basilar artery 
plaques in 42% of patients with pontine infarctions and normal basilar angiograms.38 
Second, this technique can help physician to identify the vulnerable plaque in the 
intracranial vessels. A recent study showed that all patients with ICAS have eccentric 
enhancing plaques when imaging is performed within weeks to months of cerebral infarcts 
within the artery territory, but none of asymptomatic plaques had enhancement.40 
Moreover, remodeling mode of intracranial atherosclerosis can be identified using high-
resolution MRI. It has been well known that atherosclerotic narrowing of arterial lumen is 
not a simple consequence of enlargement of atherosclerotic burden.41 Recent investigations 
with patients with intracranial atherosclerotic stenosis revealed that some compensatory 
enlargement of vessels (positive remodeling) which is associated with more lipid-rich 
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plaques42, 43 was more frequently observed in symptomatic patients compared with 
asymptomatic ones.44, 45 Lastly, risk factors for the presence of intracranial plaque have been 
reported36 and several drug therapies (i.e. statin) could modify plaque stability. In addition, 
the effects of such therapeutic intervention could be monitored using high-resolution MRI. 
3.3 Collateral image 
MRA can evaluate the cerebral collateral circulation in the circle of Willis. With phase 
contrast MRA, flow direction information can be obtained by the phase changes in blood 
water protons in the different arterial segments of the circle of Willis.46 Although MRA have 
moderate to good diagnostic performance for the presence of collateral flow via the anterior 
circle of Willis, MRA tends to underestimate the presence of collateral flow with respect to 
the posterior communicating artery. Compared to conventional angiography which is 
considered as a gold standard for the assessment of collaterals, MRA collateral flow 
measurements via the anterior part of the circle of Willis yielded a sensitivity, specificity, 
positive predictive value, negative predictive value and accuracy of 83%, 77%, 78%, 82% and 
80%, respectively. On the other hand, MRA collateral flow measurements via the posterior 
communicating artery yielded a sensitivity, specificity, positive predictive value, negative 
predictive value and accuracy of 33%, 88%, 89%, 31% and 47%, respectively.47-49 Recently, 
vessel-encoded arterial spin labeling technique was developed to assess collateral 
circulations.50-52   
Beside the collateral circulation via the circle of Willis, leptomeningeal collaterals also play 
an important role in patients with ICAS. The leptomeningeal collateral can be visualized 
using a dedicated MRI method (subtracting the image of the first movement map).53 Beside 
the vessel images, various MRI parameters can indirectly reflect the collateral status, e.g. 
DWI, PWI, and FLAIR. We found that, compared to the large cortical DWI pattern, the 
deep-infarcts pattern exhibited less severe hypoperfusion related to good collateral flows.54 
In addition, distal hyperintense vessels on fluid-attenuated inversion recovery image likely 
represent excessively slow flow induced by retrograde collateral flow distal to the occlusion 
of a proximal artery, and may be associated with leptomeningeal collaterals and response to 
thrombolysis.55, 56 A recent study using 7-tesla MRI directly visualized the pial branches, 
indicating the possibility of assessment of leptomeningeal collaterals with high-resolution 
MRA [Figure 4 E].57  
4. Conclusion 
Patients with ICAS often received the same treatment as those with extracranial carotid 
atherosclerosis. However, there are accumulating evidences that hemodynamic features as 
well as stroke mechanisms may differ between ICAS and other stroke subtypes.24, 58, 59 Using 
MRI techniques to understanding pathophysiologies, hemodynamic status, and vascular 
pathology (via both luminal and wall imaging) will allow the future development of rational 
stroke therapies for patients with ICAS. 
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and brain ischemia imaging. The new high resolution intracranial plaque imaging of the branch athermanous
disease, to the hemodynamic of intracranial atherosclerotic stroke and quantitative MRA imaging in
neurovascular imaging, are the topics in this section. Also this section covers the future prospective and the
new frontiers MRI angiography is exploring. In the third section, MRA of aortic disease in children with
emphasis on cardiac MRA.
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